Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

04 Feb 2022

18.25

0.61%

SAST

Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Enterprises

pdf

Lasa Supergenerics Ltd.

29 Jan 2022

18.25

0.61%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for To Consider, Approve And Take On …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of The Board of Director of the Company is scheduled to be held on Monday, February 07, 2022 to consider, approve and take on record of Un-audited financial results along with limited review report for the quarter ended December 31, 2021 and / or to discuss and any other business / matter with the permission of chair.

pdf

Lasa Supergenerics Ltd.

21 Jan 2022

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended December 31, 2021

BSE India

Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here

Lasa Supergenerics Ltd.

12 Jan 2022

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Intimation Of Filing Of An Application Before The National Company …

BSE India

We wish to inform you that a petition is being filed under Section 7 of Insolvency and Bankruptcy Code, 2016 by Bank of Baroda, alleged Financial Creditor of the Company through Mrs. Rathina Maravarman, Advocate for Financial Creditor before the National Company Law Tribunal- Mumbai Branch alleging default in payment amounting to Rs. 26,79,46,546.25 (Twenty Six crore Seventy nine lakhs forty six thousand five hundred and forty six rupees and twenty five paisa) (Including alleged interest and penalties) and seeking initiation of Corporate Insolvency Resolution Process (CIRP) against the Company

pdf

Lasa Supergenerics Ltd.

07 Jan 2022

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended December 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita ShettyDesignation :- Company Secretary and Compliance Officer

Lasa Supergenerics Ltd.

07 Jan 2022

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Lasa Supergenerics Ltd.

31 Dec 2021

18.25

0.61%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. January 01, 2022 till 48 hours after the declaration of financial results (both days inclusive) for the quarter ended December 31, 2021.

pdf

Lasa Supergenerics Ltd.

27 Dec 2021

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We wish to inform you that the Company is conducting analyst meet for Pharma Sector Analyst

pdf

Lasa Supergenerics Ltd.

16 Dec 2021

18.25

0.61%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is the copy of Media Release titled Hon'ble High Court of Judicature at Bombay ordered 'Closure dated 06.10.2021 of MPCB shall not be acted on and it shall be treated as show cause Notice'

pdf

Lasa Supergenerics Ltd.

13 Dec 2021

18.25

0.61%

SAST

Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 13, 2021 for Omkar Pravin Herlekar

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%